Skip to main content
. 2020 Oct 9;21(20):7437. doi: 10.3390/ijms21207437
CSC Cancer stem cell
FDA Food and Drug Administration
PDAC Pancreatic ductal adenocarcinoma
PaCSC Pancreatic CSC
SRC Proto-oncogene tyrosine-protein kinase SRC
SFKs SRC-family kinases
FYN Proto-oncogene tyrosine-protein kinase Fyn
YES Yamaguchi sarcoma
BLK B-lymphoid tyrosine kinase
FRL FYN-related kinase
YRK YES-related kinase
FGR Gardner–Rasheed feline sarcoma
HCK Hematopoietic cell kinase
LCK Lymphocyte specific kinase
LYN Tyrosine-protein kinase LYN
SRMS SRC-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites
PDX Patient-derived xenografts
TCGA The Cancer Genome Atlas
NET Neuroendocrine tumors
LNM Lymph node metastasis
ADEX Aberrantly differentiated endocrine exocrine
GSEA Gene Set Enrichment Analysis
mTOR Mammalian target of rapamycin,
TGF-ß Tumor growth factor-beta
RNAseq RNA sequencing
DAS Dasatinib
PP2 4-Amino-5-(4-chlorophenyl)-7-(dimethylethyl)pyrazolo[3,4-d]pyrimidine
CXCR4 C-X-C chemokine receptor type 4
ABCG2 ATP-binding cassette superfamily G member 2
KLF4 Kruppel-like factor 4
SOX2 SRY-box 2
POU5F1 POU Class 5 Homeobox 1
RTqPCR Real-time quantitative polymerase chain reaction
TN-BCSC Triple-negative breast cancer stem cells
JAK2 Janus kinase 2